HALLEY Venture Partners
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at HALLEY Venture Partners.
Key people at HALLEY Venture Partners.
Key people at HALLEY Venture Partners.
HALLEY Venture Partners is a San Francisco-based venture capital firm founded in 2017 that specializes in early-stage investments in the legal cannabis, hemp, and related agricultural technology sectors. Their mission is to build highly scalable companies that drive innovation in the cannabis industry, particularly focusing on technology and medical applications. The firm supports startups through Seed to Series B rounds, leveraging deep industry expertise to navigate the complex and rapidly evolving cannabis market. HALLEY’s portfolio includes companies like Willow Industries and Front Range Biosciences, reflecting their focus on biotech, healthtech, and cannabis-related innovations[1][2].
The firm was founded by Steven J. Schuman, who brings 17 years of experience in public and private equity investing across agriculture, technology, and manufacturing. Key partners include Aaron Taffet, with a strong background in private equity and cannabis operations, supported by advisors with extensive venture capital and cannabis distribution experience. HALLEY’s origin story is rooted in recognizing the once-in-a-lifetime growth opportunity presented by the legalization and expansion of the cannabis industry, aiming to back visionary founders shaping this emerging market[1][2][4].
HALLEY Venture Partners rides the secular growth trend of cannabis legalization and commercialization, a market poised to exceed $100 billion with full federal legalization in the U.S. Their timing is critical as the cannabis industry transitions from prohibition to mainstream acceptance, creating vast opportunities for technology-driven innovation in cultivation, biotech, retail, and medical applications. By focusing on scalable tech and medical companies, HALLEY influences the broader ecosystem by accelerating the professionalization and technological advancement of cannabis businesses[1][2][4].
Looking ahead, HALLEY Venture Partners is well-positioned to capitalize on the continued legalization momentum and increasing investor interest in cannabis technology and biotech. Trends such as federal legalization, advances in cannabis-derived medical treatments, and integration of Web 3.0 technologies in the sector will likely shape their investment focus. As the cannabis market matures, HALLEY’s influence may expand beyond early-stage investing to include larger growth rounds and possibly international opportunities, reinforcing their role as a key catalyst in the cannabis innovation ecosystem[1][2].
In summary, HALLEY Venture Partners combines deep sector expertise, a focused investment thesis, and a hands-on approach to build transformative companies in the burgeoning legal cannabis and hemp industries, capturing a rare and significant market opportunity.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | Willow Industries | $2.0M Series A | — | — |
| May 1, 2021 | Lucid Green | $3.0M Seed | — | — |
| Aug 1, 2020 | springbig | $12.0M Series B | — | — |
| Apr 1, 2020 | RICOVR Healthcare | $1.0M Seed | — | — |
| Dec 1, 2017 | springbig | $3.0M Venture Round | — | — |
